"The study, which was also a randomized clinical trial, tracked participants for an average of five years. The volunteers took icosapent ethyl, which is sold under the brand name Vascepa and was developed by the Amarin Corporation, which funded Bhatt's research."

Because if they spun the study as a success, the funders of this study, a pharmaceutical company, wouldn't be able to promote their drug.